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Abstract—Diabetes mellitus (DM) is a metabolic disorder 
characterised by increased blood glucose concentrations 
resulting from a deficiency of insulin, or insulin resistance. 
The prolonged hyperglycaemia of DM is extensively 
recognised as the causal link between diabetes and diabetic 
complications. Moreover, hyperglycaemia induces protein 
glycation and the formation of advanced glycation end-
products (AGEs). The accumulation of AGE in the body 
leads to structural and functional modifications of tissue 
proteins. Herein we evaluate the anti-glycation activities of 
several inhibitors i.e. S-allyl cysteine (SAC), N-
acetylcysteine (NAC) and synthesised small molecule 
inhibitors that mimic SAC/NAC (compounds A, B and C) 
identified as inhibiting the formation of methylglyoxal 
(MG)-derived AGE. The extent of glycation in the presence 
and absence of SAC, NAC and compound A were assessed 
by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE). It has been established that 
SAC, NAC and compound A, are inhibitors of protein 
glycation.  
 
Index Terms—Glycation, Advanced glycation end-product, 
diabetes, aged garlic extract; S-allyl cysteine, N-
acetylcysteine 
 
I. INTRODUCTION 
Diabetes Mellitus (DM) is a metabolic, multiple 
aetiology disease characterised by long-term 
hyperglycaemia. When untreated, it may lead to severe 
medical complications such as chronic hyperglycaemia 
and disturbances in the metabolism of protein, fat and 
carbohydrate [1], [2]. Hyperglycaemia is defined as a 
condition when elevated sugar levels are present in the 
blood. Diabetics are at increased risk of developing 
macrovascular and microvascular diseases. Diabetes-
associated complications include peripheral nerve 
damage (diabetic neuropathy), renal failure (diabetic 
nephropathy), retinal damage (diabetic retinopathy), 
cataract formation, accelerated atherosclerosis leading to 
increased risk of myocardial infarction and stroke, 
elevated blood pressure, dyslipidaemia and impaired 
wound healing [3]. The Maillard reaction or non-
enzymatic browning, refers to any chemical reaction 
involving the interaction between amino acids  and 
carbonyl compounds. The Maillard reaction is linked to 
                                                         
Manuscript received February 15, 2018; revised May 5, 2018. 
hyperglycaemia, which contributes towards the 
pathogenesis of diabetic complications via increased 
protein glycation and the formation of advanced glycation 
end-products (AGEs) [4]-[6]. Glycation and AGE 
formation are accompanied by increased free radical 
activity, which can induce damage in important 
biomolecules in cells and induce malignant cell 
transformation. Moreover, protein glycation occurs 
gradually in the body’s tissues and alters enzyme activity, 
immunogenicity, decreases ligand binding, and leads to 
protein cross-linking [4]. 
Glycation and AGE-mediated complications in 
diabetes and ageing have assisted the research for 
identifying the substances which can target glycation and 
AGE. Two main approaches were adopted to inhibit the 
formation of AGE and to break the existing protein-
protein cross-links. Compounds that inhibit the formation 
of AGE can act via a variety of mechanisms and at 
different stages of the glycation reaction. Some of these 
compounds are multifunctional AGE inhibitors working 
at different stages of the glycation reaction.. Metformin, a 
widely used hypoglycaemic agent, reduces α-dicarbonyl 
levels and inhibits AGEs formation by binding to MG in 
vivo [7]. Herbs and dietary supplements have long been 
used for glycaemic control in diabetes [8]. Recently, there 
has been  greater interest in  identifying natural products 
with anti-glycation properties. Allium sativum, commonly 
known as garlic, has been used as a flavouring agent, 
functional food and in folklore medicine for many 
centuries [9]. Aged garlic extract (AGExt) possesses 
potent antioxidant activity. It is aged for 20 months from 
natural garlic in order to reduce its harsh, irritating taste 
and smell. Nevertheless, this AGExt has a higher 
concentration of sulfur-containing compounds such as 
alliin and S-allyl cysteine (SAC) that are potent 
antioxidant and free radical scavengers [10]. The 
essential ingredient from AGExt responsible for the anti-
glycation properties of AGEs was SAC, which proved an 
effective inhibitor of AGEs. Furthermore, studies have 
shown that four organosulfur compounds derived from 
garlic, diallylsulfide, SAC, and N-acetylcysteine (NAC), 
protect LDL against oxidation and glycation and may, 
therefore, explain why garlic protects against 
cardiovascular disease [11].  
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II. MATERIALS AND METHODS 
A. Materials and Chemicals 
SAC and NAC were supplied by Wakunaga 
Pharmaceutical Company, Tokyo, Japan. Three 
synthesized mimic compounds (A, B, and C) based on 
the structures of SAC and NAC are shown in Fig 1. 
Compound A contains a benzyl replacement for the allyl 
group in SAC. Compound B contains a protected 
carboxylic acid moiety to compare with NAC. Compound 
C contains an alternative sulfur protecting group as a 
comparison to compound A. 
Lysozyme and MG were purchased from Sigma, UK. 
Silver staining kit was obtained from Bio-Rad, UK. 
Sodium dodecyl sulphate was obtained from ICN 
Biomedical Incorporation, Ohio, USA. 
 
Figure 1.  Structure of compounds A, B and C derived from SAC and 
NAC 
B. In Vitro Glycation of Proteins 
Lysozyme (10 mg/ml) was incubated in 0.1 M MG ± 
0.25 - 250 µg/ml SAC & NAC mixture and the 
synthesised mimic compound A respectively, in 0.1 M 
sodium phosphate buffer containing 3.0 mM sodium 
azide, pH 7.4 at 37°C for 1 and 3 days, respectively. 
C.  Analysis of Crosslinked Advanced Glycation End 
Products  
Glycated proteins were assessed by using 15% sodium 
dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) 
[12]. Following SDS-PAGE, silver staining was carried 
out according to the manufacturer’s recommendations 
using the silver stain kit from Bio-Rad. Briefly, the gel 
was fixed with gentle agitation in a solution of 40% (v/v) 
methanol, 10% (v/v) acetic acid and 10% (v/v) fixative 
enhancer concentrate. After decanting the fixing solution, 
the gel was rinsed in 400 mL deionised H2O for 40 min 
with three changes of water after every 10 min. The gel 
was then stained in the staining and developing solution 
for 20 minutes. The staining reaction was stopped by 
placing the gel in a 5% (v/v) solution of acetic acid. This 
was followed by rinsing the gel in deionised H2O for 5 
minutes. Protein incubated under the same conditions 
without the addition of sugars and inhibitors was used as 
a negative control. 1 µL of protein was mixed with 9 µl 
treatment buffer, and then boiled for 10 min, and then 
loaded into the wells followed by 2 μL of bromophenol 
blue and then subjected to electrophoresis using the mini-
Protean® 3 apparatus (Bio-Rad Laboratories, Hemel 
Hempstead, UK). 
D. Imaging SDS-PAGE Gels 
The gels were photographed using ChemiDoc™ Touch 
Imaging System (Bio-Rad, UK). All the bands were 
compared within the same gel. Integrated Density (I.D.) 
was measured to analyse the one-dimensional 
electrophoretic gels and computed using the following 
formula:  
I.D. = N × (mean – background). Where N is number 
of pixels in the selection and the background is the modal 
grey value (most common pixel value) after smoothing 
the histogram. Sufficient background was included in the 
selection to avoid errors. 
E. Percentage Inhibition of Cross-linked AGEs  
This was calculated using the following formula:  
100 × (I.D without inhibitor - I.D with inhibitor) / I.D 
without inhibitor. 
F.  Statistical Analysis 
Data are reported as the mean ± standard deviation 
(SD). Student’s t-test was performed to test the statistical 
significance. Values were considered significant with a p-
value <0.005. All the values (mean, SD and p-value) 
were calculated using Microsoft® Excel 2013. Statistical 
significance between groups was tested by t-tests and 
one-way analysis of variance (Oneway ANOVA). The 
analysis was performed by the statistical package IBM 
SPSS Statistics for Windows, version 22.0 (IBM). 
III. RESULTS AND DISCUSSION 
A. Effect of SAC and NAC on Inhibition of 
Methylglyoxal-derived AGE Cross-link Formation  
Fig. 2 and Fig. 3 showed that the effect of SAC and 
NAC on inhibition of MG-derived AGEs cross-link 
formation. SAC and NAC are cysteine-derived amino 
acids present at a notably higher concentration in AGExt 
compared to raw garlic. Additional studies were carried 
out to find whether SAC and NAC could be responsible 
for the inhibition of AGE formation observed in the 
glycation studies with AGExt. The results showed that 
the effects of SAC and NAC are best visible in the dimer 
band which was used to calculate the percentage 
inhibition relative to lysozyme glycation. Lysozyme 
incubated in the presence of glucose produces sufficient 
cross-linked AGEs. Cross-linking of AGEs causes 
formation of dimers with an approximate molecular 
weight of 28.6 kDa. The glycated lysozyme (Fig. 2 A and 
Fig. 3 A, lane 2) was used as the positive control and 
native lysozyme was used as negative control (Fig. 2 A 
and Fig. 3 A, lane 1). The inhibition of AGEs by SAC 
and NAC showed a reduction in the intensity of the 
dimerized lysozyme band (Fig. 2 A and Fig. 3 A, lanes 3-
9). Image analysis of the gel was performed and the 
results based on the integrated density of each band are 
presented in Fig. 2 B and Fig. 3 B. Integrated densities of 
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bands within the same gel were compared for image 
analysis. SAC inhibited the formation of cross-linked 
AGEs in a dose-dependent manner (Fig. 2 B). A 44.72% 
inhibition in the formation of cross-linked AGEs was 
observed at a 100μg/ml concentration of SAC. This 
increased to a 56.9, 64.3 and 74.6% inhibition at SAC 
concentrations of 150, 200 and 250 μg /ml respectively. 
NAC was a more potent inhibitor of the formation of 
cross-linked AGEs (Fig. 3 B). A 49.8% of inhibition in 
the formation of cross-linked AGEs was observed at a 50 
μg/mL. This increased to 68.3, 75.9 and 85.8% inhibition 
at concentrations of 150, 200 and 250 μg/mL of NAC 
respectively. The inhibition of formation of cross-linked 
AGEs achieved at 50 μg/ml of NAC was significantly 
(p<0.005) higher than that achieved at 100 μg/mL of 
SAC. The results represent one of the two independent 
experiments. The bar chart was made from the average of 
two independent experiments that showed similar results. 
 
 
Figure 2.  Effect of different SAC concentrations on MG-derived AGE 
formation; (A) Gel showing lysozyme (10 mg/ml) incubated alone (lane 
1) or in the presence of 0.1 M methylglyoxal for 1 day and the effect of 
0, 1, 10, 50, 100, 150, 200 and 250 μg /ml of SAC (lanes 2-9 
respectively) on dimerization. The cross-linked AGEs were analysed 
using SDS- PAGE and stained with silver stain. (B) Bar chart show the 
percentage inhibition of cross-linked AGEs at different concentrations 
of SAC. 
 
Figure 3.  Effect of different NAC concentration on MG-derived AGE 
formation; (A) Gel showing lysozyme (10 mg/ml) incubated alone (lane 
1) or in the presence of 0.1 M methylglyoxal for 3 days and the effect of 
0, 1, 10, 50, 100, 150, 200 and 250 μg /ml of NAC (lanes 2-9 
respectively) on dimerization. The cross-linked AGEs were analysed 
using SDS-PAGE and stained with silver stain. (B) Bar chart showing 
the percentage inhibition of cross-linked AGEs at different 
concentrations of NAC. 
B. Effect of SAC Alone, NAC Alone and SAC and NAC 
Mixture on the Formation of Cross-linked AGEs 
The experimental data on the effect of SAC alone, 
NAC alone and SAC and NAC mixture incubation with 
different incubation times (1 day and 3 days) on the 
formation of cross-linked AGEs are shown in (Fig. 4). 
SAC and NAC mixture was also tested to determine its 
role in the inhibition of cross-linked AGEs. This 
experiment was designed to compare in parallel the 
effects of SAC alone, NAC alone and SAC and NAC 
mixture in vitro cross-linked AGEs formation. Incubation 
of lysozyme with MG produced sufficient cross-linked 
AGEs to cause the formation of dimers with an 
approximate molecular weight of 28 kDa. The glycated 
lysozyme (Fig. 4 A and C, lane 2) was used as the control 
and clearly showed reduced electrophoretic mobility with 
a higher molecular weight as compared with native 
lysozyme (Fig. 4 A and C, lane 1). The results showed 
that the SAC and NAC mixture incubated for 3 days 
provided a more potent inhibition of the formation of 
cross-linked AGEs (Fig. 4 C, lanes 5 and 8) than SAC 
alone and NAC alone (Fig. 4 C, lanes 4, 6 and 7). The 
formation of cross-linked AGEs in vitro was significantly 
(p< 0.001) inhibited by the SAC and NAC mixture as 
compared to SAC alone and NAC alone (Fig. 4 B and D) 
and this inhibition was dependent on SAC and NAC 
mixture as optimum (62.7%) inhibition was observed in 
the sample with 0.5 μg/mL of SAC and NAC mixture 
while the percentage inhibitions produced by SAC alone 
were 24% and 17.5% of NAC alone. As a result, the 
effect of SAC and NAC mixture produces a stronger 
inhibition and in a dose-dependent manner. The results 
represent one of two independent experiments. The bar 
chart was made from the average of two independent 
experiments that showed similar results. 
 
 
Figure 4.  Effect of SAC alone, NAC alone and SAC and NAC mixture 
for 1 and 3 days’ incubation on the formation of cross-linked AGEs; 
gels showing lysozyme (10 mg/ml) incubated alone (lane 1) or in the 
presence of 0.1 M MG (lane 2) in 0.1 M sodium phosphate buffer, pH 
7.4 at 37 °C for 1 day (A) and 3 days (C). SAC 0.5 μg/ml (lane 3), NAC 
0.5 μg/ml (lane 4), SAC and NAC mixture 0.25μg/ml each (lane 5), 
SAC 0.25 μg/ml (lane 6), NAC 0.25 μg/ml (lane 7) and SAC and NAC 
mixture 0.125μg/ml each (lane 8). The cross-linked AGEs were 
analysed using SDS-PAGE and stained with silver stain. Bar charts 
show the percentage inhibition of cross-linked AGEs in different 
concentrations of SAC alone, NAC alone and SAC and NAC mixture 
for 1 day (B) and 3 days (D). 
C. Effect of SAC and NAC Mixture and Compound A 
Alone on the Formation of Cross-linked AGEs 
Comparison of the effect of SAC and NAC mixture 
and compound A alone on cross-linked AGEs formation 
in vitro is shown in (Fig. 5 A). Incubation of lysozyme 
with MG generates subunits of cross-linked AGEs that 
cause the formation of dimers with an approximate 
molecular weight of 28 kDa as determined by molecular 
weight markers (Fig. 5 A, lane L). The glycated lysozyme 
(Fig. 5 A, lane 2) was the positive control and clearly 
showed reduced electrophoretic mobility as compared 
with native lysozyme (Fig. 5 A, lane 1). However, 
proteins that were incubated with MG at 0.1 M for 3 days 
in the presence of SAC and NAC mixture, and 
compound A alone (Fig. 5 A, lanes 3-8) were found to 
inhibit AGE formation causing a reduction in the 
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intensity of the dimerized lysozyme band. Image analysis 
of the gel was performed and the results based on 
integrated density of each band are presented in Fig. 5 B. 
Integrated densities of bands within the same gel were 
compared for image analysis. Results showed that both 
SAC and NAC mixture and compound A alone were 
significant (p<0.001) in reducing MG-derived cross-
linked AGEs in vitro. Compound A alone showed a 
significant (p<0.001) inhibition of AGEs formation at 0.5 
and 5 µg/mL. On the other hand, SAC and NAC mixture 
showed only a non-significant inhibition between 
concentrations of 0.5 – 5 µg/mL. The percentage 
inhibitions of 0.25, 5 and 5 µg/mL of compound A alone 
were 14, 25 and 71.4% respectively, while the percentage 
inhibitions by SAC and NAC mixture were 6.5, 9.5 and 
21.8% respectively, at the same tested concentrations. 
Compound B and C did not show any significant 
inhibition of glycation (data not shown). Therefore, the 
inhibition of SAC and NAC mixture and Compound A 
alone occur in a dose-dependent manner. At all tested 
concentrations, Compound A showed a stronger 
inhibitory effect than SAC and NAC mixture in MG-
derived cross-linked AGEs in vitro, (Fig. 5 B). The 
results represent one of the two independent experiments. 
The bar chart was made from the average of two 
independent experiments that showed similar results. 
 
Figure 5.  Effect of different concentrations of SAC and NAC mixture 
and mimic compound A alone on MG-induced cross-linked AGEs 
formation; (A) Lysozyme (10 mg/ml) was incubated for 3 days alone 
(lane 1) and in the presence of 0.1 M MG (lane 2) in 0.1 M sodium 
phosphate buffer, pH 7.4 at 37 °C and the effect of different 
concentrations of SAC and NAC mixture and Mimic compound A 
alone (5, 0.5 and 0.25 µg/ml, lanes 3-4, 5-6 and 7-8 respectively). The 
cross-linked AGEs were analyzed using SDS-PAGE followed with 
silver stain. (B) Bar chart shows the percentage inhibition of cross-
linked AGEs in different concentrations of SAC and NAC mixture and 
Mimic compound A alone. (M: SAC and NAC mixture, A: Mimic 
Compound A alone). 
IV. CONCLUSION 
In the present study, protein glycation was established 
in vitro by incubation of proteins with glycating agents in 
order to accelerate the reaction rates to detect AGEs 
formation over a short period of time at physiological pH. 
MG was used as the glycating agent in this study because 
α-oxoaldehydes are formed by fragmentation and
dehydration of hexoses and Amadori products, and the 
concentration of MG is increased in diabetes. Lysozyme 
is a good model protein for the measurement of cross- 
linked AGEs formation, as oligomerisation occurs 
immediately and is easily detectable by SDS-PAGE. The 
data presented in this study indicate that anti-glycation 
activity of AGExt is mainly due to organo sulfur 
compounds present. SAC, NAC are inhibitors of 
glycation, and they may prevent the oxidative stress 
associated with the formation of AGEs and implicated in 
the diabetic complications. In this study, we chose a 
mimic compound A, due to its similar structure but 
greater effectiveness than SAC and NAC. The anti-
glycation properties of Compound A may offer greater 
therapeutic potential compared to other AGEs inhibitors. 
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